It seems likely that, by analogy with the role of Aβ in AD, that mutations which increase the concentration of the free tau are one case of disease, and some of the predisposition to sporadic disease is encoded by loci involved in the clearance of this protein. This evidence concerns the gene MAPT and Alzheimer disease.